help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/ajpath.2007.070033 on May 24, 2007

Published online before print May 24, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ajpath.2007.070033v1
171/1/68    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, M.
Right arrow Articles by Sakai, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tanaka, M.
Right arrow Articles by Sakai, R.
(American Journal of Pathology. 2007;171:68-78.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.070033

Phosphorylation of Ephrin-B1 Regulates Dissemination of Gastric Scirrhous Carcinoma

Masamitsu Tanaka*, Reiko Kamata*, Misato Takigahira{dagger}, Kazuyoshi Yanagihara{dagger} and Ryuichi Sakai*

From the Growth Factor Division,* Central Animal Laboratory,{dagger} National Cancer Center Research Institute, Tokyo, Japan

Interaction of the Eph family of receptor protein tyrosine kinase and its ligand ephrin family induces bidirectional signaling via cell-cell contacts. High expression of B-type ephrin is frequently found in various cancer cells, and their expression levels are associated with high invasion of tumors and poor prognosis. However, whether ephrin-B1 actually promotes invasion of cancer cells in vivo has not been shown. We investigated the involvement of ephrin-B1 in regulating the invasiveness of scirrhous gastric cancer, which is a diffusely infiltrative carcinoma with high invasion potential. Reduction of ephrin-B1 expression by short inter-fering RNA or overexpression of phosphorylation-defective mutant suppressed migration and invasion of scirrhous gastric cancer cells in vitro without affecting tumor cell proliferation and apoptosis. Blocking of tyrosine phosphorylation of ephrin-B1 attenuates not only dissemination of cancer cells injected intraperitoneally but also local invasion and dissemination of orthotopically implanted cancer cells in the gastric wall of nude mice. Furthermore, blocking of ephrin-B1 phosphorylation attenuated the activation of Rac1 GTPase in these invasive gastric cancer cells. Our results suggest that tyrosine phosphorylation of ephrin-B1 promotes invasion of cancer cells in vivo and is a potential therapeutic target in some types of gastrointestinal cancers.




This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
Y. Wang
Wnt/Planar cell polarity signaling: A new paradigm for cancer therapy
Mol. Cancer Ther., August 1, 2009; 8(8): 2103 - 2109.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
J. O. Bush and P. Soriano
Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism
Genes & Dev., July 1, 2009; 23(13): 1586 - 1599.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Uekita, M. Tanaka, M. Takigahira, Y. Miyazawa, Y. Nakanishi, Y. Kanai, K. Yanagihara, and R. Sakai
CUB-Domain-Containing Protein 1 Regulates Peritoneal Dissemination of Gastric Scirrhous Carcinoma
Am. J. Pathol., June 1, 2008; 172(6): 1729 - 1739.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
M. Lackmann and A. W. Boyd
Eph, a Protein Family Coming of Age: More Confusion, Insight, or Complexity?
Sci. Signal., April 15, 2008; 1(15): re2 - re2.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.